PremiumThe FlyAmbrx Biopharma downgraded to Market Perform from Outperform at JMP Securities Ambrx Biopharma downgraded to Neutral from Buy at B. Riley Ambrx Biopharma downgraded to Neutral from Buy at BTIG PremiumThe FlyAmbrx Biopharma to be added to the Nasdaq Biotechnology Index Ambrx Biopharma provides update on APEX-01 Cantor biotech/biopharma analysts hold analyst/industry conference call PremiumThe FlyFly Insider: Ambrx, Intuitive Surgical among week’s notable insider trades Largest borrow rate increases among liquid names Largest borrow rate increases among liquid names 
